✦ LIBER ✦

The role of surgery in the treatment of stage III non—small-cell lung cancer

✍ Scribed by Amy E. Gallo; Jessica S. Donington

Publisher: Current Science Inc.
Year: 2007
Tongue: English
Weight: 303 KB
Volume: 9
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-007-0030-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PET-CT in the staging and treatment of n

PET-CT in the staging and treatment of non-small-cell lung cancer

✍ Patricia Ibeas; Blanca Cantos; José Manuel Gasent; Begoña Rodríguez; Mariano Pro 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 161 KB

The role of positron emission tomography

The role of positron emission tomography in staging of non-small cell lung cancer

✍ Sheila C. Rankin 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 307 KB

Perioperative chemotherapy of stage III

Perioperative chemotherapy of stage III N2 non-small cell lung cancer

✍ Yongfeng Yu; Shun Lu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 161 KB

The Optimal Chemotherapy for Stage III N

The Optimal Chemotherapy for Stage III Non–Small Cell Lung Cancer Patients

✍ Shirish M. Gadgeel 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 146 KB

Results of Surgical Treatment After Neoa

Results of Surgical Treatment After Neoadjuvant Chemotherapy for Stage III Non-Small Cell Lung Cancer

✍ Angelo Carretta; Paola Ciriaco; Giulio Melloni; Imad Sayed; Alessandro Bandiera; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 215 KB

Resection of stage III non-small cell lu

Resection of stage III non-small cell lung cancer following induction therapy

✍ Valerie W. Rusch 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 779 KB

Approximately 25%-30% of all patients with non-small cell lung cancer (NSCLC) present with stage III tumors. Except for specific subsets, these tumors are not usually amenable to complete surgical resection and are associated with a 5-year survival of 10% or less. Because patients with stage III NSC